上半年行情收官,基金“中考”成绩也新鲜出炉。截至6月30日,汇添富香港优势精选混合以超85%的收益率暂时拔得头筹。值得注意的是,在上半年港股创新药强势行情的带动下,业绩前十榜单中,七席被重仓港股创新药的医药主题基金霸屏,产品收益率悉数涨超60%。有业内人士表示,部分产品上半年通过投资于快速成长且前景广阔的创新药企业,抓住了行业上升期的机会,后市港股创新药有望延续“戴维斯双击”行情。还有分析人士指出...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.